Mounjaro-induced nausea is coded as R11.0 (Nausea) followed by Y42.3 (Adverse effects of insulin and oral hypoglycaemic drugs) to indicate the causative medication in UK clinical practice
GLP-1 receptor agonists in the treatment of type 2 diabetes state-of-the-art
Contact your GP if fatigue is severe, significantly impairs daily functioning, persists despite self-management strategies, or is accompanied by signs of dehydration, hypoglycaemia, persistent vomiting, or symptoms suggesting nutritional deficiency such as pale skin or muscle weakness
Ready to Build Your Foundation
Reports submitted to safety monitoring systems have increased significantly, signaling a need for updated labeling and stronger warnings
However, the effectiveness can vary among individuals